IL-8 receptor (Repligen)

白细胞介素-8受体

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIL-8 receptor (Repligen)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionInterleukin-8 modulators
TargetsInterleukin-8
Therapy Area/IndicationsShockPsoriasisLupus Erythematosus, Systemic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesRepligen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRepligen
Active IndicationsN/A
Inactive IndicationsShockPsoriasisLupus Erythematosus, Systemic +[6] 

Other Information

ATC CodeN/A
Related LinksN/A